Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study

Pretreatment with solifenacin (5 mg) failed to decrease the incidence and severity of CRBD after TUR-BT.